Why Asthma Research Matters Right Now
Asthma affects roughly 25 million people in the United States, and despite the range of inhalers and pills available, a significant portion of patients live with symptoms that interfere with sleep, exercise, and everyday life. The American Lung Association notes that many individuals with moderate to severe asthma continue to experience exacerbations even while using dual maintenance therapy. That gap between available treatments and actual symptom control is what drives the research community.
Clinical trials are the engine behind every asthma medication that exists today. From the biologic therapies that target specific inflammatory pathways to the combination inhalers that simplify daily routines, someone volunteered to test these treatments before they reached the public. The landscape has shifted considerably in recent years, with trials now exploring targeted antibody treatments, novel oral medications like brenipatide, and triple-therapy inhalers — the kind that was approved for asthma in early 2026 as the first of its class for patients 12 and older.
What makes this moment particularly interesting is the diversity of studies recruiting across the country. Some trials are looking at eosinophilic asthma, a subtype driven by high levels of a particular white blood cell. Others focus on patients with obesity-related asthma, children with poorly controlled symptoms, or adults who have never been on a biologic before. This means there may be a study that matches your specific asthma profile more closely than you would expect.
Types of Asthma Clinical Trials Available
Not all asthma clinical trials look the same. Understanding the differences can help you decide which path to explore.
Phase II trials test whether a drug works and at what dose. These are typically smaller, involving a few dozen to a couple hundred participants. If you join one, you may be among the first people to receive a treatment that researchers believe has real potential.
Phase III trials are larger — often enrolling hundreds or thousands of people across multiple states and countries — and compare the investigational treatment against either a placebo or the current standard of care. The SOLAIRIA studies evaluating GB-0895 for severe uncontrolled asthma, for instance, are global Phase III trials recruiting adults and adolescents at sites throughout the United States.
Phase IV trials happen after a drug is already on the market. They gather longer-term safety data and sometimes explore whether the medication works for other conditions. These tend to carry less uncertainty because the treatment has already been through the regulatory process.
Beyond phases, there are also observational studies where no experimental drug is given. Instead, researchers track your asthma over time, sometimes using imaging, blood tests, or breathing assessments to understand how the disease behaves. The ReNORM study, for example, examines whether airway remodeling can reverse in adults who achieve clinical remission — a question that requires no new drug, just careful observation.
| Trial Type | What It Involves | Typical Time Commitment | Compensation Range | Best For |
|---|
| Phase II (early-stage) | Experimental drug, frequent monitoring | 6-18 months with multiple visits | Variable; often includes travel stipends | Those willing to try newer treatments under close supervision |
| Phase III (late-stage) | Investigational drug vs. placebo or standard care | 12-24 months, visits every 1-2 months | Broader range; some studies offer up to several thousand dollars | Patients seeking structured, multi-site research |
| Phase IV (post-market) | Approved medication, long-term follow-up | 1-5 years, fewer visits | Modest stipends per visit | Those wanting lower-risk participation |
| Observational studies | No drug; tests, imaging, questionnaires | Weeks to months, fewer visits | Screening compensation often $50-$125 | People curious about their asthma subtype |
| Focus groups & surveys | One-time discussion panels or questionnaires | Hours to days | Typically $100-$350 per session | Those with limited time who still want to contribute |
Finding Trials Near You and What to Expect
The most straightforward starting point is ClinicalTrials.gov, a database maintained by the National Library of Medicine. You can search by typing "asthma" in the condition field, then filter by "Recruiting" status and your state or city. The site shows you the study purpose, eligibility criteria, locations, and contact information — all in one place.
But local resources are equally valuable. Major academic medical centers run asthma research programs that may not always appear at the top of a national search. The American Lung Association's Airways Clinical Research Centers network spans sites in Arizona, Illinois, New York, North Carolina, and Vermont, each running multiple trials at any given time. Boston Children's Hospital has a dedicated Asthma and Allergy Clinical Research Center. Icahn School of Medicine at Mount Sinai in New York regularly recruits for asthma studies. Velocity Clinical Research operates over 70 sites across the country and frequently lists asthma trials.
Once you find a study that interests you, the process generally follows a predictable path. First comes a screening visit, where the research team explains the study in detail, answers your questions, and asks you to sign an informed consent form. They will run tests — lung function assessments, blood work, maybe allergy skin testing — to determine if you meet the eligibility criteria. Some studies compensate you for screening regardless of whether you qualify. UVA's asthma research program, for instance, offers up to $125 for completing the screening process.
If you qualify, you enter the treatment phase. Depending on the study design, you may receive the investigational drug, a placebo, or the standard treatment. Visits might happen monthly, every other month, or on a schedule specific to the protocol. During these visits, the team checks your lung function, reviews your symptom diary, and monitors for any side effects. Some trials include overnight stays; others are entirely outpatient or even hybrid, with some assessments done from home via telehealth.
Compensation varies widely. Shorter focus groups and survey-based studies tend to pay between $100 and $350 per session. Longer clinical trials offer more substantial stipends to reflect the time commitment — Clinical Research of West Florida has compensated participants up to $1,100 for asthma trials, while Brigham and Women's Hospital reports up to $3,900 for a study involving 26 visits over nearly two years. These amounts are not wages but rather reimbursement for your time, travel, and the inconvenience of multiple clinic visits.
Is It Right for You? A Realistic Look
Take Sarah, a 41-year-old teacher in Phoenix with moderate persistent asthma. She used her albuterol inhaler three or four times a week despite taking a daily controller medication. Her doctor mentioned that the University of Arizona's Asthma and Airway Disease Research Center was recruiting for a trial. Sarah was hesitant — she worried about receiving a placebo and about the time commitment. After speaking with the research coordinator, she learned the study allowed her to continue her current medications while adding either the investigational drug or a placebo on top. The visits were once a month, scheduled on Saturdays, and parking was covered. She joined, and while she does not know whether she received the active drug, she says the monthly lung function checks gave her a clearer picture of her asthma than she had ever had before.
Eligibility criteria are the gatekeepers. Most asthma trials require a physician-confirmed diagnosis and a minimum age — often 18, though pediatric studies recruit younger children and adolescent trials frequently start at age 12. Severity matters too. Some trials want patients with mild allergic asthma; others specifically seek those with severe, uncontrolled disease despite using high-dose inhaled corticosteroids. Your current medications, smoking history, other health conditions, and even your body weight can all factor into whether you qualify.
Safety is the question everyone asks, and rightfully so. Every clinical trial in the United States must be reviewed and approved by an Institutional Review Board, an independent ethics committee that evaluates whether the risks are reasonable relative to the potential benefits. You can withdraw at any time, for any reason. The informed consent document you sign is not a contract — it is an explanation of what you are agreeing to, and you carry no obligation to continue if you change your mind.
Taking the Next Step
If you are curious about asthma clinical trials near me, start with the American Lung Association's clinical trial finder or ClinicalTrials.gov. Write down the name of your current asthma medications, your most recent lung function test results if you have them, and a list of questions — about the study drug, the visit schedule, the compensation structure, and what happens after the trial ends. Then call the research coordinator listed on the study page. These conversations are not commitments; they are simply a way to learn whether the study fits your life.
For parents considering pediatric asthma research studies, the conversation is different. Children cannot legally consent, so you as the parent or guardian provide permission while the child gives assent if they are old enough to understand. Pediatric trials tend to have extra layers of safety monitoring, and the research teams are typically experienced in making kids feel comfortable with procedures like spirometry or blood draws.
The decision to join a clinical trial is personal. It involves weighing inconvenience against access, uncertainty against the possibility of improvement. What makes it worthwhile for many participants is knowing that their involvement — whether they benefit directly or not — pushes the science forward for everyone who struggles to breathe freely.
研究の知恵